Skip to main content
TipRanks
Go Ultimate75% OFF

High Tide (HITI) AI Stock Analysis

351 Followers
TSE:HITI

High Tide

(TSXV:HITI)

Select Model
Rating:61Neutral
Price Target:CAD 3.50▲(2.94% Upside)
Action:reiterated
Date:09/22/26

The score is driven primarily by mixed financial quality (strong multi-year revenue scaling and positive TTM free cash flow, but ongoing TTM net losses and margin compression) and a very upbeat earnings call emphasizing record operating performance and confident growth plans. Technicals are supportive with the stock trading above major moving averages and neutral-to-positive momentum indicators, while valuation is constrained by the negative P/E and lack of dividend support.

Positive Factors
Revenue GrowthHigh Tide has demonstrated substantial multi-year revenue scaling, supported by another record quarterly result. Continued growth across both retail and medical distribution indicates expanding customer reach and provides a stronger base for operating leverage and future earnings development.
Negative Factors
Persistent Losses and Margin CompressionRevenue growth has not yet translated into consistent profitability. Persistent losses and materially lower gross margins constrain retained cash generation, weaken returns on capital, and leave less room to absorb competitive pricing pressure or invest aggressively without relying on operating improvements.

High Tide (HITI) vs. iShares MSCI Canada ETF (EWC)

-30%-20%-10%0%10%20%30%TSE:HITI-8.11%EWC+16.25%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CAD 210.38M
Dividend Yield
―
Average Volume (3M)
76.92K
Price to Earnings (P/E)
-9.0
Beta (1Y)
1.57
Revenue Growth
26.79%
EPS Growth
-215.02%
Country
Canada
Employees
1,832
Sector
Healthcare
Sector Strength
51
Industry
Medical - Pharmaceuticals

High Tide Business Overview & Revenue Model

Company Description

High Tide Inc. operates as a prominent global player in the cannabis retail sector, with business activities spanning Canada, Europe, the United States, and other international markets. The company's portfolio is multifaceted, including the design, m...

How the Company Makes Money

High Tide primarily makes money by selling cannabis products to adult-use consumers through its brick-and-mortar retail stores (its largest operating focus). Revenue is generated at the point of sale from a broad assortment that typically includes dr...

High Tide Earnings Call Summary

Earnings Call Date:Sep 14, 2026(Q3-2026)|% Change Since:-7.86%|Next Earnings Date:Apr 01, 2019
Earnings Call SentimentPositive

The call was strongly positive, with record revenue, EBITDA, operating income, net income, cash flow, customer membership, Canadian market share, and German medical cannabis volumes. Management also highlighted improving expense ratios, strong liquidity, continued organic expansion, and disciplined international growth plans. The principal challenges were Canadian consumer pressure, thinner baskets, industry competition and store growth, potential market contraction, German import quota timing, and price compression. These issues were acknowledged but did not outweigh the broad-based financial and operational momentum.

Positive Updates

Record Revenue and Broad-Based Financial Performance
Q3 revenue reached a record CAD 198.8 million, up 33% year-over-year and 11% sequentially, marking the fifth consecutive quarter with a new all-time revenue high and the fastest growth rate in 13 quarters. Both the bricks-and-mortar and medical cannabis distribution segments posted record results.

Negative Updates

Canadian Consumer Pressure and Thinner Baskets
Management said Canadian consumers are facing macroeconomic uncertainty, creeping inflation, job stress, and trade-war-related pressure. Although transaction counts increased 1.1% and customers were not leaving, customers were purchasing less per visit, including choosing ounce bags instead of 3.5-gram products.

Company Guidance

Management reiterated its long-term goal of 3 million members in Canada, plans to add 118 stores in Canada, a goal of adding 20 Cabanas during this calendar year, and a long-term target to reach 350 locations across the country; combined with Remexian’s current trajectory, this makes the company “more confident than ever” it will breach the CAD 1 billion revenue mark in the not-too-distant future. Management said Remexian will reach a higher steady state volume level than originally expected, may gain further share in Germany, and continues its march towards a 15%-20% market share in the long term; medical distribution gross margins could be “very much in the high or mid-20s going forward” and are expected to settle in the “mid to high 20s over the long term.”

High Tide Financial Statement Overview

Summary

Revenue has scaled materially over several years and TTM cash generation is positive (operating cash flow 24.7M; free cash flow 15.7M). However, profitability remains the main drag with a TTM net loss (-33.3M) and negative net margin (-4.6%), alongside notable gross margin compression versus the most recent annual period. Leverage is improving (debt down; debt-to-equity ~1.17), but ROE remains deeply negative (~-36%).

Income Statement

38Negative

Balance Sheet

44Neutral

Cash Flow

62Positive
Financial statement breakdown
BreakdownTTMOct 2025Oct 2024Oct 2023Oct 2022Oct 2021
Income Statement
Total Revenue720.47M593.99M522.31M487.67M356.85M181.12M
Gross Profit100.14M153.53M142.50M131.31M100.95M63.98M
EBITDA4.20M-13.74M33.78M-4.20M-33.65M-1.96M
Net Income-33.34M-50.75M-4.34M-39.31M-70.85M-35.04M
Balance Sheet
Total Assets369.35M349.06M246.21M233.40M274.74M246.22M
Cash, Cash Equivalents and Short-Term Investments47.19M47.95M47.98M30.26M25.28M14.87M
Total Debt123.47M149.83M74.61M72.53M69.88M55.43M
Total Liabilities249.42M246.28M100.70M99.73M112.71M94.21M
Stockholders Equity105.22M87.61M143.27M131.56M156.35M147.21M
Cash Flow
Free Cash Flow15.74M13.43M25.80M14.58M-4.56M-13.54M
Operating Cash Flow24.66M23.87M35.55M20.66M4.50M-2.83M
Investing Cash Flow-23.95M-22.29M-11.01M-5.72M-8.59M-28.49M
Financing Cash Flow-16.60M202.00K-7.72M-9.26M15.17M37.81M

High Tide Technical Analysis

Technical Analysis SentimentNegative
Last Price3.40

Price Trends

50DMA3.71Negative
100DMA3.47Negative
200DMA3.38Positive

Market Momentum

MACD-0.06Positive
RSI35.91Neutral
STOCH5.49Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:HITI, the sentiment is Negative. The current price of 3.40 is below the 20-day moving average (MA) of 3.66, below the 50-day MA of 3.71, and above the 200-day MA of 3.38, indicating a neutral trend. The MACD of -0.06 indicates Positive momentum. The RSI at 35.91 is Neutral, neither overbought nor oversold. The STOCH value of 5.49 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:HITI.

High Tide Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

TSE:HITI against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TSE:HITITSE:HITI61NeutralCAD 303.08M-8.98-36.06%―26.79%-215.02%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
TSE:TSNDTSE:TSND50NeutralCAD 212.28M-5.68-25.94%―-3.88%82.25%
TSE:WEEDTSE:WEED50NeutralCAD 346.20M-1.01-39.36%―10.67%74.14%
TSE:JUSHTSE:JUSH49NeutralCAD 113.83M-1.4440.14%―5.37%17.78%
TSE:AYR.ATSE:AYR.A40NeutralCAD 18.10M-0.03-74.75%―――
TSE:PLTHTSE:PLTH39UnderperformCAD 38.56M-1.06-59.17%―-15.64%71.65%

* Healthcare Sector Average

Performance Comparison

0%100%200%TSE:HITITSE:WEEDTSE:JUSHTSE:AYR.ATSE:PLTHTSE:TSNDDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TSE:HITI and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TSE:HITIHigh Tide, Inc.3.40-0.29-7.86%
TSE:WEEDCanopy Growth0.72-0.72-50.00%
TSE:JUSHJushi Holdings Inc0.570.059.62%
TSE:AYR.AAyr Wellness Inc.0.150.000.00%
TSE:PLTHPlanet 13 Holdings, Inc.0.12-0.12-52.08%
TSE:TSNDTerrascend0.52-0.03-5.45%

High Tide Corporate Events

Business Operations and StrategyM&A Transactions

High Tide Buys Cash-Flowing Chestermere Cannabis Store to Boost Canna Cabana Network

Positive
Oct 9, 2026

High Tide Inc. has acquired an established cannabis retail store in Chestermere, Alberta, for $670,000 in cash and will rebrand it under its Canna Cabana banner, lifting its Canadian store count to 234 and Alberta locations to 93. The Chestermere out...

Business Operations and StrategyExecutive/Board ChangesRegulatory Filings and Compliance

High Tide Expands Canna Cabana Network with First Peterborough Store and Grants Director RSUs

Positive
Oct 1, 2026

High Tide Inc. plans to open its first Canna Cabana store in Peterborough, Ontario, on October 15, 2026, pending regulatory approval, bringing its Canadian Canna Cabana footprint to 233 locations, including 107 in Ontario. The new store sits in a hig...

Business Operations and Strategy

High Tide’s Canna Cabana Tightens Grip on Canadian Cannabis Retail Market

Positive
Sep 22, 2026

High Tide’s Canna Cabana brand has emerged as the leading cannabis retailer in Canada in terms of national brand awareness and consumer shopping habits, according to a Q3 2026 report from media agency Rebel & Thorn. Awareness among cannabis consumers...

Business Operations and Strategy

High Tide Adds Three Canna Cabana Stores in Targeted Canadian Expansion

Positive
Aug 31, 2026

High Tide is expanding its Canna Cabana footprint in Canada with three new stores in Lindsay and Orléans, Ontario, and Regina, Saskatchewan, pending regulatory approval. The openings, scheduled between September 2 and 5, 2026, will lift its Canadian...

Business Operations and StrategyFinancial DisclosuresRegulatory Filings and Compliance

High Tide Sets Date for Q3 2026 Results and Investor Webcast

Neutral
Aug 25, 2026

High Tide Inc., a leading cannabis retailer and distributor, plans to release its financial and operational results for the third fiscal quarter ended July 31, 2026, after markets close on September 14. The results will be accessible to investors via...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 22, 2026